Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. (Record no. 15952268)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02041 a2200565 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515010442.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200602s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1524-4539 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1161/CIRCULATIONAHA.105.555623 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Yano, Masafumi |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20060222 |
245 00 - TITLE STATEMENT | |
Title | Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Circulation |
Date of publication, distribution, etc. | Dec 2005 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 3633-43 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antioxidants |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antipyrine |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Calcium |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cardiac Pacing, Artificial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dogs |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Edaravone |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heart Failure |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heart Ventricles |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Muscle Cells |
General subdivision | cytology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nitric Oxide Donors |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxidative Stress |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Structure, Tertiary |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ryanodine Receptor Calcium Release Channel |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sarcoplasmic Reticulum |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tacrolimus Binding Protein 1A |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ventricular Remodeling |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Okuda, Shinichi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Oda, Tetsuro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tokuhisa, Takahiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tateishi, Hiroki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mochizuki, Mamoru |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Noma, Toshiyuki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Doi, Masahiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kobayashi, Shigeki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yamamoto, Takeshi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ikeda, Yasuhiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ohkusa, Tomoko |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ikemoto, Noriaki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Matsuzaki, Masunori |
773 0# - HOST ITEM ENTRY | |
Title | Circulation |
Related parts | vol. 112 |
-- | no. 23 |
-- | p. 3633-43 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1161/CIRCULATIONAHA.105.555623">https://doi.org/10.1161/CIRCULATIONAHA.105.555623</a> |
Public note | Available from publisher's website |
No items available.